Top Markets
#1 Tensor Tensor +38.02%
#2 Blur Blur +20.11%
#3 Dymension Dymension +19.49%
#4 Supra Supra +15.93%
#5 XPIN Network XPIN Network +14.16%
#6 Irys Irys +13.12%
#7 Corn Corn +12.16%
#8 Ontology Gas Ontology Gas +12.16%
#9 Naoris Protocol Naoris Protocol +11.04%
#10 Enjin Coin Enjin Coin +9.82%
Coin of the day
Tensor Tensor
設定
言語
日本
通貨
USD
テーマ
Abbott Laboratories Abbott Laboratories

Abbott Laboratories

ABT
株式のランク #84
Abbott Laboratories, together with its subsidiaries, discovers, develops,... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
株価
$101.91
時価総額
$177.09B
変化（1日）
-1.97%
変化（1年）
-19.78%
国
US
取引 Abbott Laboratories (ABT)

カテゴリー

Healthcare
Abbott Laboratories（ABT）のP/E比率
April 2026 時点のP/E比率 TTM 27.47
Abbott Laboratories の最新の財務報告および株価によると、現在の P/E (TTM) は 27.47 です。2024 年末時点での P/E は 14.62 でした。
Abbott Laboratories の P/E 比率の履歴（2000 〜 2026）
各年末のP/E比率
年 P/E比率 変化
2026 (TTM) 27.47 -18.12%
2025 33.55 129.56%
2024 14.62 -56.18%
2023 33.35 20.14%
2022 27.76 -21.42%
2021 35.33 -18.19%
2020 43.19 3.69%
2019 41.65 -22.33%
2018 53.63 -74.29%
2017 208.61 416.25%
2016 40.41 170.24%
2015 14.95 -49.70%
2014 29.72 29.04%
2013 23.04 177.98%
2012 8.29 -7.25%
2011 8.93 16.57%
2010 7.66 10.25%
2009 6.95 -13.90%
2008 8.07 -29.75%
2007 11.49 -44.65%
2006 20.76 139.13%
2005 8.68 -19.34%
2004 10.76 -9.48%
2003 11.89 18.37%
2002 10.05 -59.93%
2001 25.07 107.16%
2000 12.10 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差 国
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 38.72 40.95%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 24.08 -12.35%
IE
Medtronic Medtronic
Medtronic
MDT.US
 24.08 -12.35%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 32.19 17.19%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SMMNY.US
 19.12 -30.39%
DE
P/E比率の読み方

株価収益率（P/E Ratio）は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の（0に近い）P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。